GSK plc vs Merck & Company, Inc. — Stock Comparison

GSK
GSK plc
$51.61
▼ 1.34%
vs
MRK
Merck & Company, Inc.
$112.16
▲ 2.73%
Q·Score Winner
Merck & Company, Inc.
MRK6.7/10vs 6.3/10

Q·Score Breakdown

6.3
Neutral
Overall
6.7
Neutral
8.5
Quality
6.2
5.8
Health
7
5.8
Growth
6.2
6.7
Valuation
7.2
3.1
Sentiment
7.1
GSK

High-quality business with 41% return on equity and 18% profit margins.

cautious analyst consensus — few Buy ratings.

MRK

Forward P/E of 11.5× is low relative to sector peers.

Analyst Consensus

HOLD
Target $57.65 (+11.7%)
8 analysts
BUY
Target $129.74 (+15.7%)
27 analysts

Fundamentals

GSK
MRK
13.4×
Trailing P/E
31.5×
9.9×
Forward P/E
11.5×
17.8%
Profit Margin
13.6%
72.9%
Gross Margin
76.6%
40.9%
ROE
1.5%
Revenue Growth
4.9%
8.4%
Earnings Growth
0.35
Beta
0.28
Price / Book
$103.0B
Market Cap
$277.0B
$35 – $62
52-Week Range
$73 – $125

Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →